MBD2 and cancer: The demethylase KDM5B is known as a potential therapeutic target for cancer treatment, based on its action as a key regulator in important biological processes of cancers such as tumorigenesis, progression and antibiotic resistance, and based on its ability to block the activation of H3K4me3.19